Table 1.
Characteristics of arthritis patients receiving intra-articular corticosteroid injections
| Characteristics | All | EMLA® or Numby®b | EMLA® or Numby® + Buffered Subcutaneous Lidocaineb |
|---|---|---|---|
| Total n (%) | 63 (100) | 28 (44.4) | 35 (55.6) |
| Agea (years) | 10.8 (8.2 – 14.4) | 11.5 (8.7 – 13.1) | 10.5 (8.2 – 14.6) |
| Range (years) | 4.7 – 20 | 4.7 – 17.9 | 6.1 – 20.0 |
| Gender | |||
| Male | 19 (30.2) | 9 (32.1) | 10 (28.6) |
| Female | 44 (69.8) | 19 (67.9) | 25 (71.4) |
| Disease Durationa (years) | 1.2 (0.2 – 4.8) | 1.4 (0.11 – 4.7) | 1.2 (0.2 –5.0) |
| Range (years) | 0 – 15.6 | 0.0 – 9.6 | 0.02 – 15.6 |
| Disease Type | |||
| Oligoarthritis | 49 (77.8) | 24 (85.7) | 25 (71.4) |
| Polyarthritis | 7 (11.1) | 2 (7.1) | 5 (14.2) |
| Systemic arthritis | 1 (1.6) | 0 (0.0) | 1 (2.9) |
| Enthesitis-Related arthritis | 1 (1.6) | 1 (3.6) | 0 (0.0) |
| Psoriatic arthritis | 2 (3.2) | 1 (3.6) | 1 (2.9) |
| Lyme arthritis | 3 (4.8) | 0 (0.0) | 3 (8.6) |
aMedian [inter-quartile range (IQR) = 25th- 75th percentile]. bNo significant difference between groups